Compare PLUS & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLUS | PRCT |
|---|---|---|
| Founded | 1990 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.8B |
| IPO Year | 1996 | 2021 |
| Metric | PLUS | PRCT |
|---|---|---|
| Price | $83.88 | $27.79 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $51.13 |
| AVG Volume (30 Days) | 178.9K | ★ 1.2M |
| Earning Date | 02-04-2026 | 02-24-2026 |
| Dividend Yield | ★ 1.19% | N/A |
| EPS Growth | ★ 28.72 | N/A |
| EPS | ★ 5.03 | N/A |
| Revenue | ★ $2,407,459,000.00 | $299,907,000.00 |
| Revenue This Year | $14.37 | $48.30 |
| Revenue Next Year | $3.17 | $29.44 |
| P/E Ratio | $14.95 | ★ N/A |
| Revenue Growth | 15.93 | ★ 50.07 |
| 52 Week Low | $53.83 | $26.66 |
| 52 Week High | $93.98 | $70.80 |
| Indicator | PLUS | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 44.03 | 39.28 |
| Support Level | $82.90 | $26.93 |
| Resistance Level | $90.78 | $30.02 |
| Average True Range (ATR) | 4.04 | 1.67 |
| MACD | -0.25 | -0.02 |
| Stochastic Oscillator | 31.62 | 19.48 |
ePlus Inc is a provider of technology solutions across the IT spectrum, spanning security, cloud, data center, networking, collaboration, AI, service provider, and critical infrastructure, and emerging solutions, to domestic and foreign organizations across all industry segments. Its solutions leverage a broad range of professional, consultative, and managed services across the technology spectrum. The company possesses top-level engineering certifications with a broad range of IT technologies that enable the company to offer multi-vendor IT solutions that are optimized for each of its customers' specific requirements. It also offers a wide portfolio of technology and other capital asset financing solutions to customers across commercial and government enterprises, designing programs.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.